[A case of pulmonary thromboembolism with heparin-induced thrombocytopenia].
In February 2000, a 70-year-old man was admitted to our hospital complaining of back pain and dyspnea on exertion. Pulmonary thromboembolism was diagnosed, and he was treated with intravenous urokinase and heparin. The pulmonary thromboembolism improved, though heparin-induced thrombocytopenia (HIT) was subsequently observed. The thrombocytopenia was then improved by withdrawing the intravenous heparin, but thrombosis appeared extending from both femoral veins to the inferior vena cava. The thrombosis was dispersed by catheter-directed thrombolysis. There have been few reports of HIT in Japan. Heparin is frequently used for the treatment of pulmonary thromboembolism, but special care must be taken, since severe thrombotic complications are associated with HIT.
Totani
Y
Y
Third Department of Internal Medicine, Fukui Medical University, Matsuoka-town, Fukui 910-1193, Japan.
Demura
Y
Y
Ameshima
S
S
Miyamori
I
I
Ishizaki
T
T
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced*
D000925:Anticoagulants; D006493:Heparin